Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Primary Care × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1094 Neoplasms 945 Carcinoma, Non-Small-Cell Lung 682 Prostatic Neoplasms 632 Colorectal Neoplasms 512 Lung Neoplasms 505 Pancreatic Neoplasms 356 Leukemia, Myeloid, Acute 350 Neoplasm Metastasis 336 Multiple Myeloma 331 Ovarian Neoplasms 321 Carcinoma, Hepatocellular 284 Stomach Neoplasms 281 Melanoma 259 Recurrence 254 Squamous Cell Carcinoma of Head and Neck 238 Brain Neoplasms 235 Lymphoma 217 Endometrial Neoplasms 216 Precursor Cell Lymphoblastic Leukemia-Lymphoma 215 Uterine Cervical Neoplasms 210 Head and Neck Neoplasms 205 Triple Negative Breast Neoplasms 204 Glioblastoma 199 Urinary Bladder Neoplasms 185 Sarcoma 184 Hematologic Neoplasms 179 Carcinoma, Renal Cell 178 Esophageal Neoplasms 176 Lymphoma, Non-Hodgkin 163

Interventions

Darbepoetin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07130487 2025-11-25

Project CARE: CAncer Risk Evaluation

Rutgers, The State University of New Jersey

Phase NA Recruiting

Primary Care

Data powered by HemOnc (CC BY 4.0) Colophon ⚡